| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCMP | Sucampo Pharmaceuticals, Inc. | Kuno Sachiko | 10% Owner | Feb 13, 2018 | Option Exercise | $18.00 | 5,137,344 | 92,472,192 | 0 | Feb 14, 2018, 05:50 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Feb 13, 2018 | Option Exercise | $18.00 | 5,406,585 | 97,318,530 | 0 | Feb 14, 2018, 05:47 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | OCONNELL MAUREEN | Director | Feb 13, 2018 | Option Exercise | $18.00 | 5,130 | 92,340 | 0 | Feb 13, 2018, 04:59 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Walbert Timothy P | Director | Feb 13, 2018 | Option Exercise | $18.00 | 5,130 | 92,340 | 0 | Feb 13, 2018, 04:59 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Spiegel Robert J. | Director | Feb 13, 2018 | Option Exercise | $18.00 | 5,130 | 92,340 | 0 | Feb 13, 2018, 04:57 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Edick Paul R | Director | Feb 13, 2018 | Option Exercise | $18.00 | 14,930 | 268,740 | 0 | Feb 13, 2018, 04:54 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Feb 13, 2018 | Option Exercise | $18.00 | 36,975 | 665,550 | 36,975 | Feb 13, 2018, 04:54 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Feb 13, 2018 | Option Exercise | $18.00 | 129,729 | 2,335,122 | 0 | Feb 13, 2018, 04:54 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | JOHNSON JOHN | Director | Feb 13, 2018 | Option Exercise | $18.00 | 5,130 | 92,340 | 0 | Feb 13, 2018, 04:52 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Feb 13, 2018 | Option Exercise | $18.00 | 44,856 | 807,408 | 0 | Feb 13, 2018, 04:51 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Lichtlen Peter | Chief Medical Officer | Feb 13, 2018 | Option Exercise | $18.00 | 24,000 | 432,000 | 0 | Feb 13, 2018, 04:48 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Feb 13, 2018 | Option Exercise | $18.00 | 263 | 4,734 | 0 | Feb 13, 2018, 04:47 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Bryan Jones W. | Sr. Vice Pres., BD & Licensing | Feb 13, 2018 | Option Exercise | $18.00 | 5,139 | 92,502 | 0 | Feb 13, 2018, 04:44 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Meyenburg Jason Patrick | Chief Commercial Officer | Feb 13, 2018 | Option Exercise | $18.00 | 30,228 | 544,104 | 0 | Feb 13, 2018, 04:41 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Driggs Alex | General Counsel & Corp. Sec. | Feb 13, 2018 | Option Exercise | $18.00 | 6,084 | 109,512 | 0 | Feb 13, 2018, 04:41 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Sep 30, 2017 | Option Exercise | $9.10 | 131 | 1,192 | 131 | Jan 12, 2018, 06:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Dec 31, 2017 | Option Exercise | $9.10 | 263 | 2,393 | 263 | Jan 12, 2018, 06:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Bryan Jones W. | Sr. Vice Pres., BD & Licensing | Dec 31, 2017 | Option Exercise | $10.24 | 439 | 4,495 | 5,139 | Jan 12, 2018, 04:36 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Dec 31, 2017 | Option Exercise | $9.10 | 171 | 1,556 | 4,792 | Jan 04, 2018, 05:16 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Dec 31, 2017 | Option Exercise | $9.10 | 329 | 2,994 | 44,856 | Jan 04, 2018, 05:16 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Dec 31, 2017 | Option Exercise | $9.10 | 330 | 3,003 | 36,975 | Jan 04, 2018, 05:15 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Driggs Alex | General Counsel & Corp. Sec. | Dec 31, 2017 | Option Exercise | $9.10 | 660 | 6,006 | 6,084 | Jan 04, 2018, 05:15 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Dec 28, 2017 | Option Exercise | $17.98 | 27,496 | 494,378 | 44,527 | Jan 02, 2018, 05:00 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Dec 28, 2017 | Option Exercise | $17.98 | 19,353 | 347,967 | 36,645 | Jan 02, 2018, 04:58 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Driggs Alex | General Counsel & Corp. Sec. | Dec 28, 2017 | Option Exercise | $17.98 | 2,025 | 36,409 | 5,424 | Jan 02, 2018, 04:56 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Dec 07, 2017 | Option Exercise | $12.41 | 100,000 | 1,241,500 | 52,023 | Dec 11, 2017, 05:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Sep 30, 2017 | Option Exercise | $9.10 | 330 | 3,003 | 2,023 | Oct 05, 2017, 04:40 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Sep 30, 2017 | Option Exercise | $9.10 | 330 | 3,003 | 2,998 | Oct 05, 2017, 04:37 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Driggs Alex | General Counsel & Corp. Sec. | Sep 30, 2017 | Option Exercise | $9.10 | 659 | 5,997 | 1,331 | Oct 05, 2017, 04:35 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | CEO | Sep 30, 2017 | Option Exercise | $9.10 | 659 | 5,997 | 4,621 | Oct 05, 2017, 04:32 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Sep 11, 2017 | Sale | $12.00 | 1,000,000 | 12,000,000 | 8,006,585 | Sep 13, 2017, 05:50 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kuno Sachiko | 10% Owner | Sep 11, 2017 | Sale | $12.00 | 1,000,000 | 12,000,000 | 7,137,344 | Sep 13, 2017, 05:50 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Meyenburg Jason Patrick | Chief Commercial Officer | Sep 06, 2017 | Buy | $12.13 | 4,000 | 48,500 | 30,228 | Sep 08, 2017, 04:40 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Bryan Jones W. | Sr. Vice Pres., BD & Licensing | Aug 04, 2017 | Buy | $10.60 | 4,700 | 49,820 | 4,700 | Aug 07, 2017, 04:35 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Jun 30, 2017 | Option Exercise | $8.93 | 336 | 3,000 | 1,693 | Jul 07, 2017, 04:46 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | CEO | Jun 30, 2017 | Option Exercise | $8.93 | 673 | 6,010 | 3,962 | Jul 07, 2017, 04:45 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Driggs Alex | Acting General Counsel | Jun 30, 2017 | Option Exercise | $8.93 | 672 | 6,001 | 672 | Jul 07, 2017, 04:40 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Jun 30, 2017 | Option Exercise | $8.93 | 336 | 3,000 | 2,668 | Jul 07, 2017, 04:35 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Gen. Council & Sec. | Jun 30, 2017 | Option Exercise | $8.93 | 673 | 6,010 | 4,763 | Jul 07, 2017, 04:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Science Officer | Mar 31, 2017 | Option Exercise | $9.35 | 321 | 3,001 | 1,357 | May 10, 2017, 04:03 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | CEO | Mar 31, 2017 | Option Exercise | $9.35 | 641 | 5,993 | 3,289 | May 10, 2017, 04:02 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | Mar 31, 2017 | Option Exercise | $9.35 | 321 | 3,001 | 2,332 | May 10, 2017, 04:02 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Gen. Council & Sec. | Mar 31, 2017 | Option Exercise | $9.35 | 641 | 5,993 | 4,224 | May 10, 2017, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Dec 31, 2016 | Option Exercise | $10.46 | 143 | 1,496 | 491 | Jan 06, 2017, 04:03 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Scientific Officer | Dec 31, 2016 | Option Exercise | $10.46 | 287 | 3,002 | 1,036 | Jan 06, 2017, 04:03 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Dec 31, 2016 | Option Exercise | $10.46 | 135 | 1,412 | 2,648 | Jan 06, 2017, 04:02 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec.VicePres,HumanResources | Dec 31, 2016 | Option Exercise | $10.46 | 286 | 2,992 | 2,011 | Jan 06, 2017, 04:02 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Dec 31, 2016 | Option Exercise | $10.46 | 134 | 1,402 | 3,583 | Jan 06, 2017, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | CEO | Nov 28, 2016 | Option Exercise | $11.83 | 235,082 | 2,781,020 | 120,054 | Nov 30, 2016, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | CEO | Nov 29, 2016 | Option Exercise | $11.75 | 164,918 | 1,937,787 | 84,972 | Nov 30, 2016, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Getman Daniel P | Director | Nov 28, 2016 | Option Exercise | $11.84 | 32,402 | 383,802 | 16,201 | Nov 30, 2016, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Getman Daniel P | Director | Nov 29, 2016 | Option Exercise | $11.78 | 7,598 | 89,466 | 3,799 | Nov 30, 2016, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Nov 23, 2016 | Option Exercise | $12.05 | 52,000 | 626,600 | 29,449 | Nov 28, 2016, 09:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Nov 25, 2016 | Option Exercise | $12.11 | 198,050 | 2,397,395 | 102,474 | Nov 28, 2016, 09:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Nov 28, 2016 | Option Exercise | $12.53 | 49,950 | 625,873 | 28,424 | Nov 28, 2016, 09:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Nov 15, 2016 | Sale | $15.58 | 1,766 | 27,514 | 348 | Nov 16, 2016, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Sep 30, 2016 | Option Exercise | $9.38 | 160 | 1,501 | 2,114 | Oct 21, 2016, 04:06 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Scientific Officer | Sep 30, 2016 | Option Exercise | $9.38 | 320 | 3,002 | 749 | Oct 21, 2016, 04:06 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Sep 30, 2016 | Option Exercise | $9.38 | 640 | 6,003 | 2,513 | Oct 21, 2016, 04:06 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec.VicePres,HumanResources | Sep 30, 2016 | Option Exercise | $9.38 | 320 | 3,002 | 1,725 | Oct 21, 2016, 04:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Sep 30, 2016 | Option Exercise | $9.38 | 639 | 5,994 | 3,449 | Oct 21, 2016, 04:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Jun 30, 2016 | Option Exercise | $9.32 | 188 | 1,752 | 1,954 | Jul 18, 2016, 05:06 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Scientific Officer | Jun 30, 2016 | Option Exercise | $9.32 | 300 | 2,796 | 429 | Jul 18, 2016, 05:06 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Jun 30, 2016 | Option Exercise | $9.32 | 751 | 6,999 | 1,873 | Jul 18, 2016, 05:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec. V.P., Human Resources | Mar 31, 2016 | Option Exercise | $9.32 | 376 | 3,504 | 1,405 | Jul 18, 2016, 05:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus. Dev.&Lic, G.C. &Sec. | Jun 30, 2016 | Option Exercise | $9.32 | 752 | 7,009 | 2,810 | Jul 18, 2016, 05:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Mar 31, 2016 | Option Exercise | $9.29 | 161 | 1,496 | 1,766 | Jun 16, 2016, 04:31 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kiener Peter A | Chief Scientific Officer | Mar 31, 2016 | Option Exercise | $9.29 | 129 | 1,198 | 129 | Jun 16, 2016, 04:31 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Mar 31, 2016 | Option Exercise | $9.29 | 646 | 6,001 | 1,122 | Jun 16, 2016, 04:31 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec. V.P., Human Resources | Mar 31, 2016 | Option Exercise | $9.29 | 323 | 3,001 | 1,029 | Jun 16, 2016, 04:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Bus.Dev.&Lic, G.C. &Sec. | Mar 31, 2016 | Option Exercise | $9.29 | 645 | 5,992 | 2,058 | Jun 16, 2016, 04:30 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Greenleaf Peter | Chief Executive Officer | Dec 31, 2015 | Option Exercise | $14.70 | 476 | 6,997 | 476 | Mar 04, 2016, 05:56 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec. V.P., Human Resources | Dec 31, 2015 | Option Exercise | $14.70 | 238 | 3,499 | 706 | Mar 04, 2016, 05:44 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Business Dev. & Licensing | Dec 31, 2015 | Option Exercise | $14.70 | 477 | 7,012 | 1,413 | Mar 04, 2016, 05:40 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Miele Stanley G | Chief Commercial Officer | Sep 30, 2015 | Option Exercise | $14.52 | 41 | 595 | 93 | Nov 20, 2015, 04:09 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Miele Stanley G | Chief Commercial Officer | Jun 30, 2015 | Option Exercise | $13.37 | 52 | 695 | 52 | Nov 20, 2015, 04:09 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Business Dev. & Licensing | Jun 30, 2015 | Option Exercise | $13.37 | 523 | 6,993 | 523 | Nov 20, 2015, 04:08 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Alder Matthias | EVP, Business Dev. & Licensing | Sep 30, 2015 | Option Exercise | $14.52 | 413 | 5,997 | 936 | Nov 20, 2015, 04:08 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec. V.P., Human Resources | Jun 30, 2015 | Option Exercise | $13.37 | 261 | 3,490 | 261 | Nov 20, 2015, 04:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Donley Matthew Maxwell | Exec. V.P., Human Resources | Sep 30, 2015 | Option Exercise | $14.52 | 207 | 3,006 | 468 | Nov 20, 2015, 04:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Smith Andrew P | Chief Financial Officer | Nov 16, 2015 | Buy | $17.03 | 1,605 | 27,333 | 1,605 | Nov 18, 2015, 04:01 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Getman Daniel P | Director | Aug 28, 2015 | Option Exercise | $15.67 | 60,000 | 940,200 | 30,000 | Aug 31, 2015, 04:57 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Knapp Thomas J | Former Officer | Jul 20, 2015 | Sale | $17.90 | 129,056 | 2,310,605 | 45,000 | Jul 22, 2015, 04:58 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kuno Sachiko | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 60,357 | 844,998 | 0 | Apr 02, 2015, 05:58 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kuno Sachiko | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 353,530 | 4,949,420 | 0 | Apr 02, 2015, 05:58 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Kuno Sachiko | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 1,186,113 | 16,605,582 | 20,274,689 | Apr 02, 2015, 05:58 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | S&R Technology Holdings, LLC | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 1,186,113 | 16,605,582 | 20,274,689 | Apr 02, 2015, 05:51 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 60,357 | 844,998 | 0 | Apr 02, 2015, 05:49 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 353,530 | 4,949,420 | 0 | Apr 02, 2015, 05:49 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Mar 31, 2015 | Sale | $14.00 | 1,186,113 | 16,605,582 | 20,274,689 | Apr 02, 2015, 05:49 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Celeste Anthony C. | Director | Mar 11, 2015 | Sale | $12.32 | 131,932 | 1,624,792 | 20,000 | Mar 18, 2015, 09:38 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ashton William | Director | Mar 11, 2015 | Option Exercise | $10.89 | 148,008 | 1,611,490 | 30,000 | Mar 18, 2015, 09:37 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ashton William | Director | Mar 12, 2015 | Sale | $12.66 | 111,524 | 1,411,582 | 20,000 | Mar 18, 2015, 09:37 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Claiborne Cary J | Dec 15, 2014 | Sale | $8.48 | 14,200 | 120,416 | 9,964 | Dec 17, 2014, 05:34 PM | ||
| SCMP | Sucampo Pharmaceuticals, Inc. | Claiborne Cary J | Dec 16, 2014 | Sale | $8.49 | 85,800 | 728,442 | 45,764 | Dec 17, 2014, 05:34 PM | ||
| SCMP | Sucampo Pharmaceuticals, Inc. | S&R Technology Holdings, LLC | 10% Owner | Aug 05, 2014 | Sale | $6.24 | 84,243 | 525,744 | 22,558,286 | Aug 07, 2014, 06:08 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | S&R Technology Holdings, LLC | 10% Owner | Aug 06, 2014 | Sale | $6.32 | 30,523 | 193,000 | 22,527,763 | Aug 07, 2014, 06:08 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | S&R Technology Holdings, LLC | 10% Owner | Aug 07, 2014 | Sale | $6.31 | 66,961 | 422,845 | 22,460,802 | Aug 07, 2014, 06:08 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Aug 05, 2014 | Sale | $6.24 | 84,243 | 525,744 | 22,558,286 | Aug 07, 2014, 06:02 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Ueno Ryuji | 10% Owner | Aug 06, 2014 | Sale | $6.32 | 30,523 | 193,000 | 22,527,763 | Aug 07, 2014, 06:02 PM |
Menu